← Leaderboards
Jane Ryan
Biota Scientific Management
$15,264,757
Attributed
$15,264,757
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.4M · FY2006–13$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$15,264,757 · 3
By mechanism
U01$8,277,264 · 1
UC1$5,628,310 · 1
R01$1,359,183 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Oral”
- Daniel R Kuritzkes · Brigham And Women'S Hospital$236,409,338
- Judith S. Currier · University Of California Los Angeles$134,347,732
- Constance Ann Benson · University Of California, San Diego$123,741,444
- Wafaa M. El-Sadr · Columbia University Health Sciences$92,413,650
- Myron S Cohen · Family Health International$91,263,426
- Robert A Wood · Johns Hopkins University$57,641,510
Research focus
OralLeadRattusPre-ClinicalResistance ProfileBiotaIn VitroIntravenousPropertyProgramsGuidelinesResistanceToxicologyRouteDoseInfectionInnovationDrug KineticsIn VivoAntiviral AgentsClinical ResearchInfluenzaBreathingGrant
Grant awards (8)
Development of Novel Inhibitors of Clostridium difficile.$1
R01 · FY2013 · AI · contact PI
Development of Novel Inhibitors of Clostridium difficile.$528,895
R01 · FY2012 · AI · contact PI
Development of Novel Inhibitors of Clostridium difficile.$830,287
R01 · FY2011 · AI · contact PI
Innovative Influenza Therapeutic and Prophylactic for Biodefense Applications$1,615,004
U01 · FY2009 · AI · contact PI
Innovative Influenza Therapeutic and Prophylactic for Biodefense Applications$2,359,731
U01 · FY2008 · AI · contact PI
Innovative Influenza Therapeutic and Prophylactic for Biodefense Applications$1,900,794
U01 · FY2007 · AI · contact PI
Innovative Influenza Therapeutic and Prophylactic for Biodefense Applications$2,401,735
U01 · FY2006 · AI · contact PI
Novel Influenza Biodefense Therapeutic and Prophylactic$5,628,310
UC1 · FY2004 · AI